MEIRAGTX LIMITED
LONDON KADMON GENE THERAPY HOLDINGS LIMITED KADMON GENE THERAPY LIMITED

Hellopages » Greater London » Hackney » N1 7NQ

Company number 09501998
Status Active
Incorporation Date 20 March 2015
Company Type Private Limited Company
Address 92 BRITANNIA WALK, LONDON, ENGLAND, N1 7NQ
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc

Since the company registration forty-six events have happened. The last three records are Statement of capital following an allotment of shares on 20 December 2016 GBP 401.77845 ; Statement of capital following an allotment of shares on 23 January 2017 GBP 401.77845 ; Statement of capital following an allotment of shares on 7 December 2016 GBP 401.77845 . The most likely internet sites of MEIRAGTX LIMITED are www.meiragtx.co.uk, and www.meiragtx.co.uk. The predicted number of employees is 1 to 10. The company’s age is ten years and nine months. The distance to to Battersea Park Rail Station is 4.4 miles; to Brondesbury Park Rail Station is 5.3 miles; to Beckenham Hill Rail Station is 7.8 miles; to Bickley Rail Station is 10.6 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Meiragtx Limited is a Private Limited Company. The company registration number is 09501998. Meiragtx Limited has been working since 20 March 2015. The present status of the company is Active. The registered address of Meiragtx Limited is 92 Britannia Walk London England N1 7nq. . FORBES, Alexandria Josefina is a Director of the company. HARRIS, Keith Reginald is a Director of the company. LEVINE, Arnold Jay is a Director of the company. MARCUS, Joel is a Director of the company. MENDOZA, Neil Francis Jeremy is a Director of the company. NAYLOR, Michael Stuart is a Director of the company. SHENK, Thomas Eugene is a Director of the company. Director WAKSAL, Samuel David has been resigned. The company operates in "Research and experimental development on biotechnology".


Current Directors

Director
FORBES, Alexandria Josefina
Appointed Date: 20 March 2015
60 years old

Director
HARRIS, Keith Reginald
Appointed Date: 30 June 2015
72 years old

Director
LEVINE, Arnold Jay
Appointed Date: 10 February 2016
86 years old

Director
MARCUS, Joel
Appointed Date: 30 June 2015
78 years old

Director
MENDOZA, Neil Francis Jeremy
Appointed Date: 30 June 2015
66 years old

Director
NAYLOR, Michael Stuart
Appointed Date: 27 April 2015
62 years old

Director
SHENK, Thomas Eugene
Appointed Date: 28 September 2015
78 years old

Resigned Directors

Director
WAKSAL, Samuel David
Resigned: 08 October 2015
Appointed Date: 20 March 2015
78 years old

MEIRAGTX LIMITED Events

27 Feb 2017
Statement of capital following an allotment of shares on 20 December 2016
  • GBP 401.77845

31 Jan 2017
Statement of capital following an allotment of shares on 23 January 2017
  • GBP 401.77845

09 Dec 2016
Statement of capital following an allotment of shares on 7 December 2016
  • GBP 401.77845

12 Oct 2016
Total exemption small company accounts made up to 31 December 2015
07 Oct 2016
Statement of capital following an allotment of shares on 30 September 2016
  • GBP 383.25993

...
... and 36 more events
14 May 2015
Statement of capital following an allotment of shares on 24 April 2015
  • GBP 224.40
  • ANNOTATION Clarification a second filed SH01 was registered on 19/06/2015

14 May 2015
Sub-division of shares on 24 April 2015
13 May 2015
Current accounting period shortened from 31 March 2016 to 31 December 2015
08 Apr 2015
Company name changed kadmon gene therapy LIMITED\certificate issued on 08/04/15
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2015-04-08

20 Mar 2015
Incorporation
Statement of capital on 2015-03-20
  • GBP 1